Australia's CSL buys Novartis influenza vaccine unit for $275 million

SYDNEY (Reuters) - Australia's CSL Ltd , the world's largest blood products company, said on Monday it had agreed to buy Novartis AG's global influenza vaccine business for $275 million.

from Reuters: Deals http://ift.tt/1ttKZat